_id
691858e93c536f8df2317b0e
Ticker
0L35.LSE
Name
Sarepta Therapeutics Inc.
Exchange
LSE
Address
215 First Street, Cambridge, MA, United States, 02142
Country
UK
Sector
Industry
Currency
USD
Website
https://www.sarepta.com
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients with Duchenne with a confirmed mutation in the Duchenne gene. The company is also developing SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Catalent Maryland, Inc.; Nationwide Children's Hospital; Dyno Therapeutics; Hansa Biopharma; Duke University; and Genethon. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Last Close
23.28
Volume
127
Current Price
23.46
Change
0.852
Last Updated
2026-01-08T14:20:17.894Z
Image
https://logo.clearbit.com/www.sarepta.com
Ipo Date
-
Market Cap
191026099200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
399356000
Cost Of Revenue
150775000
Gross Profit
248581000
Operating Expenses
351970000
Operating Income
-103389000
Interest Expense
7565000
Pretax Income
-194049000
Net Income
-179947000
Eps
-1.7952153396450412
Dividends Per Share
-
Shares Outstanding
66823600
Income Tax Expense
-14102000
EBITDA
-168034000
Operating Margin
-25.88893117919851
Total Other Income Expense Net
-90660000
Cash
613077000
Short Term Investments
237916000
Receivables
541604000
Inventories
1077166000
Total Current Assets
2722309000
Property Plant Equipment
498103000
Total Assets
3493437000
Payables
94015000
Short Term Debt
10168000
Long Term Debt
-
Total Liabilities
2173317000
Equity
1320120000
Bs_currency_symbol
-
Depreciation
18450000
Change In Working Capital
-29228000
Cash From Operations
-14585000
Capital Expenditures
28246000
Cash From Investing
232400000
Cash From Financing
-117790000
Net Change In Cash
100025000
Cf_currency_symbol
-
PE
-
PB
1.7813229251886193
ROE
-13.631109293094568
ROA
-5.151001721227547
FCF
-42831000
Fcf Percent
-0.10725017277817286
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
399356000
Quarters > 0 > income Statement > cost Of Revenue
150775000
Quarters > 0 > income Statement > gross Profit
248581000
Quarters > 0 > income Statement > operating Expenses
351970000
Quarters > 0 > income Statement > operating Income
-103389000
Quarters > 0 > income Statement > interest Expense
7565000
Quarters > 0 > income Statement > pretax Income
-194049000
Quarters > 0 > income Statement > net Income
-179947000
Quarters > 0 > income Statement > eps
-1.7952153396450412
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
100237000
Quarters > 0 > income Statement > income Tax Expense
-14102000
Quarters > 0 > income Statement > EBITDA
-168034000
Quarters > 0 > income Statement > operating Margin
-25.88893117919851
Quarters > 0 > income Statement > total Other Income Expense Net
-90660000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
613077000
Quarters > 0 > balance Sheet > short Term Investments
237916000
Quarters > 0 > balance Sheet > receivables
541604000
Quarters > 0 > balance Sheet > inventories
1077166000
Quarters > 0 > balance Sheet > total Current Assets
2722309000
Quarters > 0 > balance Sheet > property Plant Equipment
498103000
Quarters > 0 > balance Sheet > total Assets
3493437000
Quarters > 0 > balance Sheet > payables
94015000
Quarters > 0 > balance Sheet > short Term Debt
10168000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2173317000
Quarters > 0 > balance Sheet > equity
1320120000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-179947000
Quarters > 0 > cash Flow > depreciation
18450000
Quarters > 0 > cash Flow > change In Working Capital
-29228000
Quarters > 0 > cash Flow > cash From Operations
-14585000
Quarters > 0 > cash Flow > capital Expenditures
28246000
Quarters > 0 > cash Flow > cash From Investing
232400000
Quarters > 0 > cash Flow > cash From Financing
-117790000
Quarters > 0 > cash Flow > net Change In Cash
100025000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-1.7952153396450412
Quarters > 0 > ratios > PB
1.7813229251886193
Quarters > 0 > ratios > ROE
-13.631109293094568
Quarters > 0 > ratios > ROA
-5.151001721227547
Quarters > 0 > ratios > FCF
-42831000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.10725017277817286
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
611091000
Quarters > 1 > income Statement > cost Of Revenue
152558000
Quarters > 1 > income Statement > gross Profit
458533000
Quarters > 1 > income Statement > operating Expenses
342956000
Quarters > 1 > income Statement > operating Income
115577000
Quarters > 1 > income Statement > interest Expense
5228000
Quarters > 1 > income Statement > pretax Income
153638000
Quarters > 1 > income Statement > net Income
196892000
Quarters > 1 > income Statement > eps
1.84661845943183
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
106623000
Quarters > 1 > income Statement > income Tax Expense
-43254000
Quarters > 1 > income Statement > EBITDA
169706000
Quarters > 1 > income Statement > operating Margin
18.913222416955904
Quarters > 1 > income Statement > total Other Income Expense Net
38061000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
510598000
Quarters > 1 > balance Sheet > short Term Investments
289541000
Quarters > 1 > balance Sheet > receivables
609595000
Quarters > 1 > balance Sheet > inventories
994036000
Quarters > 1 > balance Sheet > total Current Assets
2656985000
Quarters > 1 > balance Sheet > property Plant Equipment
514898000
Quarters > 1 > balance Sheet > total Assets
3679814000
Quarters > 1 > balance Sheet > payables
136702000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2322429000
Quarters > 1 > balance Sheet > equity
1357385000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
196892000
Quarters > 1 > cash Flow > depreciation
10840000
Quarters > 1 > cash Flow > change In Working Capital
49534000
Quarters > 1 > cash Flow > cash From Operations
261337000
Quarters > 1 > cash Flow > capital Expenditures
31984000
Quarters > 1 > cash Flow > cash From Investing
32211000
Quarters > 1 > cash Flow > cash From Financing
-23817000
Quarters > 1 > cash Flow > net Change In Cash
269731000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
1.84661845943183
Quarters > 1 > ratios > PB
1.8427900558795038
Quarters > 1 > ratios > ROE
14.505243538126619
Quarters > 1 > ratios > ROA
5.350596524715652
Quarters > 1 > ratios > FCF
229353000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.3753172604407527
Quarters > 1 > health Score
76
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
744856000
Quarters > 2 > income Statement > cost Of Revenue
137564000
Quarters > 2 > income Statement > gross Profit
607292000
Quarters > 2 > income Statement > operating Expenses
907678000
Quarters > 2 > income Statement > operating Income
-300386000
Quarters > 2 > income Statement > interest Expense
4503000
Quarters > 2 > income Statement > pretax Income
-383518000
Quarters > 2 > income Statement > net Income
-447508000
Quarters > 2 > income Statement > eps
-4.596331217518128
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
97362000
Quarters > 2 > income Statement > income Tax Expense
63990000
Quarters > 2 > income Statement > EBITDA
-369037000
Quarters > 2 > income Statement > operating Margin
-40.328063410914325
Quarters > 2 > income Statement > total Other Income Expense Net
-83132000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
240867000
Quarters > 2 > balance Sheet > short Term Investments
281895000
Quarters > 2 > balance Sheet > receivables
724524000
Quarters > 2 > balance Sheet > inventories
941432000
Quarters > 2 > balance Sheet > total Current Assets
2432533000
Quarters > 2 > balance Sheet > property Plant Equipment
507650000
Quarters > 2 > balance Sheet > total Assets
3465387000
Quarters > 2 > balance Sheet > payables
156105000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2322664000
Quarters > 2 > balance Sheet > equity
1142723000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-447508000
Quarters > 2 > cash Flow > depreciation
9978000
Quarters > 2 > cash Flow > change In Working Capital
-281777000
Quarters > 2 > cash Flow > cash From Operations
-583437000
Quarters > 2 > cash Flow > capital Expenditures
45889000
Quarters > 2 > cash Flow > cash From Investing
-291177000
Quarters > 2 > cash Flow > cash From Financing
12471000
Quarters > 2 > cash Flow > net Change In Cash
-862143000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-4.596331217518128
Quarters > 2 > ratios > PB
1.9988330680313602
Quarters > 2 > ratios > ROE
-39.16154658653059
Quarters > 2 > ratios > ROA
-12.913651491161016
Quarters > 2 > ratios > FCF
-629326000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.8448961947007206
Quarters > 2 > health Score
20
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
658412000
Quarters > 3 > income Statement > cost Of Revenue
132304000
Quarters > 3 > income Statement > gross Profit
526108000
Quarters > 3 > income Statement > operating Expenses
364427000
Quarters > 3 > income Statement > operating Income
161681000
Quarters > 3 > income Statement > interest Expense
4475000
Quarters > 3 > income Statement > pretax Income
171743000
Quarters > 3 > income Statement > net Income
159049000
Quarters > 3 > income Statement > eps
1.4662407581540278
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
108474000
Quarters > 3 > income Statement > income Tax Expense
12694000
Quarters > 3 > income Statement > EBITDA
186673000
Quarters > 3 > income Statement > operating Margin
24.55620492943628
Quarters > 3 > income Statement > total Other Income Expense Net
10062000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1103010000
Quarters > 3 > balance Sheet > short Term Investments
251782000
Quarters > 3 > balance Sheet > receivables
649728000
Quarters > 3 > balance Sheet > inventories
749960000
Quarters > 3 > balance Sheet > total Current Assets
3073463000
Quarters > 3 > balance Sheet > property Plant Equipment
488646000
Quarters > 3 > balance Sheet > total Assets
3963173000
Quarters > 3 > balance Sheet > payables
214442000
Quarters > 3 > balance Sheet > short Term Debt
13473000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2435431000
Quarters > 3 > balance Sheet > equity
1527742000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
159049000
Quarters > 3 > cash Flow > depreciation
10455000
Quarters > 3 > cash Flow > change In Working Capital
-124994000
Quarters > 3 > cash Flow > cash From Operations
92046000
Quarters > 3 > cash Flow > capital Expenditures
38082000
Quarters > 3 > cash Flow > cash From Investing
764118000
Quarters > 3 > cash Flow > cash From Financing
48991000
Quarters > 3 > cash Flow > net Change In Cash
905155000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
1.4662407581540278
Quarters > 3 > ratios > PB
1.665726307190612
Quarters > 3 > ratios > ROE
10.410723800222813
Quarters > 3 > ratios > ROA
4.013173283124406
Quarters > 3 > ratios > FCF
53964000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.08196083910985827
Quarters > 3 > health Score
58
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1901979000
Annuals > 0 > income Statement > cost Of Revenue
319099000
Annuals > 0 > income Statement > gross Profit
1582880000
Annuals > 0 > income Statement > operating Expenses
1364799000
Annuals > 0 > income Statement > operating Income
218081000
Annuals > 0 > income Statement > interest Expense
18391000
Annuals > 0 > income Statement > pretax Income
260774000
Annuals > 0 > income Statement > net Income
235239000
Annuals > 0 > income Statement > eps
2.1806628041714946
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
107875000
Annuals > 0 > income Statement > income Tax Expense
25535000
Annuals > 0 > income Statement > EBITDA
316889000
Annuals > 0 > income Statement > operating Margin
11.466004619399058
Annuals > 0 > income Statement > total Other Income Expense Net
42693000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
1103010000
Annuals > 0 > balance Sheet > short Term Investments
251782000
Annuals > 0 > balance Sheet > receivables
649728000
Annuals > 0 > balance Sheet > inventories
749960000
Annuals > 0 > balance Sheet > total Current Assets
3073463000
Annuals > 0 > balance Sheet > property Plant Equipment
488646000
Annuals > 0 > balance Sheet > total Assets
3963173000
Annuals > 0 > balance Sheet > payables
214442000
Annuals > 0 > balance Sheet > short Term Debt
13473000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2435431000
Annuals > 0 > balance Sheet > equity
1527742000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
235239000
Annuals > 0 > cash Flow > depreciation
37724000
Annuals > 0 > cash Flow > change In Working Capital
-716606000
Annuals > 0 > cash Flow > cash From Operations
-205787000
Annuals > 0 > cash Flow > capital Expenditures
146956000
Annuals > 0 > cash Flow > cash From Investing
755561000
Annuals > 0 > cash Flow > cash From Financing
124806000
Annuals > 0 > cash Flow > net Change In Cash
674580000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
2.1806628041714946
Annuals > 0 > ratios > PB
1.6565280656027002
Annuals > 0 > ratios > ROE
15.397822407186554
Annuals > 0 > ratios > ROA
5.935622795169426
Annuals > 0 > ratios > FCF
-352743000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.18546103821335566
Annuals > 0 > health Score
57
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1243336000
Annuals > 1 > income Statement > cost Of Revenue
150343000
Annuals > 1 > income Statement > gross Profit
1092993000
Annuals > 1 > income Statement > operating Expenses
1360817000
Annuals > 1 > income Statement > operating Income
-267824000
Annuals > 1 > income Statement > interest Expense
22010000
Annuals > 1 > income Statement > pretax Income
-520098000
Annuals > 1 > income Statement > net Income
-535977000
Annuals > 1 > income Statement > eps
-5.800742440312561
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
92398000
Annuals > 1 > income Statement > income Tax Expense
15879000
Annuals > 1 > income Statement > EBITDA
-453691000
Annuals > 1 > income Statement > operating Margin
-21.540758089526886
Annuals > 1 > income Statement > total Other Income Expense Net
-252274000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
428430000
Annuals > 1 > balance Sheet > short Term Investments
1247820000
Annuals > 1 > balance Sheet > receivables
436975000
Annuals > 1 > balance Sheet > inventories
322859000
Annuals > 1 > balance Sheet > total Current Assets
2579331000
Annuals > 1 > balance Sheet > property Plant Equipment
357106000
Annuals > 1 > balance Sheet > total Assets
3264576000
Annuals > 1 > balance Sheet > payables
164918000
Annuals > 1 > balance Sheet > short Term Debt
123328000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2405239000
Annuals > 1 > balance Sheet > equity
859337000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-535977000
Annuals > 1 > cash Flow > depreciation
44397000
Annuals > 1 > cash Flow > change In Working Capital
-481089000
Annuals > 1 > cash Flow > cash From Operations
-500993000
Annuals > 1 > cash Flow > capital Expenditures
87345000
Annuals > 1 > cash Flow > cash From Investing
-165803000
Annuals > 1 > cash Flow > cash From Financing
125004000
Annuals > 1 > cash Flow > net Change In Cash
-541792000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-5.800742440312561
Annuals > 1 > ratios > PB
2.5224761414904746
Annuals > 1 > ratios > ROE
-62.370990659077876
Annuals > 1 > ratios > ROA
-16.417966682350173
Annuals > 1 > ratios > FCF
-588338000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.47319308698533624
Annuals > 1 > health Score
20
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
933013000
Annuals > 2 > income Statement > cost Of Revenue
139989000
Annuals > 2 > income Statement > gross Profit
793024000
Annuals > 2 > income Statement > operating Expenses
1329225000
Annuals > 2 > income Statement > operating Income
-536201000
Annuals > 2 > income Statement > interest Expense
53248000
Annuals > 2 > income Statement > pretax Income
-689963000
Annuals > 2 > income Statement > net Income
-703488000
Annuals > 2 > income Statement > eps
-8.034445345424228
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
87559000
Annuals > 2 > income Statement > income Tax Expense
13525000
Annuals > 2 > income Statement > EBITDA
-594851000
Annuals > 2 > income Statement > operating Margin
-57.469831610063316
Annuals > 2 > income Statement > total Other Income Expense Net
-153762000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
966777000
Annuals > 2 > balance Sheet > short Term Investments
1022597000
Annuals > 2 > balance Sheet > receivables
261600000
Annuals > 2 > balance Sheet > inventories
203968000
Annuals > 2 > balance Sheet > total Current Assets
2557861000
Annuals > 2 > balance Sheet > property Plant Equipment
244991000
Annuals > 2 > balance Sheet > total Assets
3128366000
Annuals > 2 > balance Sheet > payables
95875000
Annuals > 2 > balance Sheet > short Term Debt
15489000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2743416000
Annuals > 2 > balance Sheet > equity
384950000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-703488000
Annuals > 2 > cash Flow > depreciation
41864000
Annuals > 2 > cash Flow > change In Working Capital
-39470000
Annuals > 2 > cash Flow > cash From Operations
-325346000
Annuals > 2 > cash Flow > capital Expenditures
32251000
Annuals > 2 > cash Flow > cash From Investing
-1046883000
Annuals > 2 > cash Flow > cash From Financing
232507000
Annuals > 2 > cash Flow > net Change In Cash
-1139722000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-8.034445345424228
Annuals > 2 > ratios > PB
5.336106351474218
Annuals > 2 > ratios > ROE
-182.74788933627744
Annuals > 2 > ratios > ROA
-22.48739437776782
Annuals > 2 > ratios > FCF
-357597000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.38327118700382523
Annuals > 2 > health Score
11
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
701887000
Annuals > 3 > income Statement > cost Of Revenue
97049000
Annuals > 3 > income Statement > gross Profit
604838000
Annuals > 3 > income Statement > operating Expenses
1064548000
Annuals > 3 > income Statement > operating Income
-459710000
Annuals > 3 > income Statement > interest Expense
63525000
Annuals > 3 > income Statement > pretax Income
-418948000
Annuals > 3 > income Statement > net Income
-418780000
Annuals > 3 > income Statement > eps
-5.153454259063277
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
81262000
Annuals > 3 > income Statement > income Tax Expense
-168000
Annuals > 3 > income Statement > EBITDA
-317406000
Annuals > 3 > income Statement > operating Margin
-65.49629783711623
Annuals > 3 > income Statement > total Other Income Expense Net
40762000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2115869000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
172745000
Annuals > 3 > balance Sheet > inventories
186212000
Annuals > 3 > balance Sheet > total Current Assets
2604099000
Annuals > 3 > balance Sheet > property Plant Equipment
236687000
Annuals > 3 > balance Sheet > total Assets
3147974000
Annuals > 3 > balance Sheet > payables
76741000
Annuals > 3 > balance Sheet > short Term Debt
15051000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2219965000
Annuals > 3 > balance Sheet > equity
928009000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-418780000
Annuals > 3 > cash Flow > depreciation
38017000
Annuals > 3 > cash Flow > change In Working Capital
-98166000
Annuals > 3 > cash Flow > cash From Operations
-443172000
Annuals > 3 > cash Flow > capital Expenditures
38490000
Annuals > 3 > cash Flow > cash From Investing
495413000
Annuals > 3 > cash Flow > cash From Financing
561569000
Annuals > 3 > cash Flow > net Change In Cash
613810000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-5.153454259063277
Annuals > 3 > ratios > PB
2.0542974475463063
Annuals > 3 > ratios > ROE
-45.126717521058524
Annuals > 3 > ratios > ROA
-13.303159428889819
Annuals > 3 > ratios > FCF
-481662000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.6862386680477057
Annuals > 3 > health Score
21
Valuation > metrics > PE
-1.7952153396450412
Valuation > metrics > PB
1.7813229251886193
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-13.631109293094568
Profitability > metrics > ROA
-6.610087245790247
Profitability > metrics > Net Margin
-0.4505929546569978
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.6463026088537405
Risk > metrics > Interest Coverage
-13.666754791804362
Risk > final Score
-25
Risk > verdict
High
Liquidity > metrics > Current Ratio
26.130069205148633
Liquidity > metrics > Quick Ratio
15.790896787383739
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
80
Prev Valuations > 2
100
Prev Profitabilities > 0
81
Prev Profitabilities > 1
0
Prev Profitabilities > 2
66
Prev Risks > 0
70
Prev Risks > 1
-249
Prev Risks > 2
70
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:55:26.604Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.7
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-03
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.7952
Earnings History > 1 > eps Estimate
-0.48
Earnings History > 1 > eps Difference
-1.3152
Earnings History > 1 > surprise Percent
-274
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
1.887
Earnings History > 2 > eps Estimate
1.16
Earnings History > 2 > eps Difference
0.727
Earnings History > 2 > surprise Percent
62.6724
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-29
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-4.5963
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
1.6121
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.3387
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.0683
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-01
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.3644
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-12
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.4324
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-01
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.4605
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-02
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.2698
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-02
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-5.8598
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-28
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-1.2437
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-02
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-2.9413
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-02
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-2.6452
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-04
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-1.2037
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-01
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-1.4192
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-03
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.6027
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-04
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-1.0208
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-05
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-2.105
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-2.3993
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-2.5031
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-1.9344
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.2289
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-3.1614
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-1.703
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-3.7373
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-1.0685
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-2.0523
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-1.1538
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-1.6686
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.5472
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients with Duchenne with a confirmed mutation in the Duchenne gene. The company is also developing SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Catalent Maryland, Inc.; Nationwide Children's Hospital; Dyno Therapeutics; Hansa Biopharma; Duke University; and Genethon. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Sarepta Therapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.7
Date
2025-09-30
EPS Actual
-1.7952
EPS Estimate
-0.48
EPS Difference
-1.3152
Surprise Percent
-274%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.